Solid Tumor
📧 Sign up to get email alerts when something new happens for Solid Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: A Phase I Study: PET Imaging of Cancer Patients Using [18F] 4-L-Fluoroglutamine (2S,4R) [Phase 1]
This update describes an ongoing Phase I clinical trial evaluating PET imaging with the radiotracer [18F] 4-L-Fluoroglutamine in patients wi…
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: Study of ART6043 in Advanced/Metastatic Solid Tumors Patients [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating ART6043 in patients with advanced/metastatic solid tumors is active but not recruiting.
-
CLINICAL_TRIALS research · 2025-10-10Clinical Trial Update: Umbilical Cord Blood Transplantation From Unrelated Donors
This is an ongoing clinical trial evaluating umbilical cord blood transplantation from unrelated donors for hematologic diseases. The study …
-
CLINICAL_TRIALS research · 2025-09-26Clinical Trial Update: A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma and Other Solid Tumors [Phase 2]
A Phase 2 study evaluating SI-B003 alone and in combination with BL-B01D1 in patients with locally advanced or metastatic urothelial carcino…
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: A Study of BL-B16D1 in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors [Phase 1]
Phase 1 study evaluating BL-B16D1 in patients with unresectable locally advanced or metastatic breast cancer and other solid tumors is curre…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: Personalised Immunotherapy Platform
Clinical trial update for a personalised immunotherapy platform; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Arginine and Whole Brain Radiation Therapy for the Treatment of Patients With Brain Metastases [EARLY_Phase 1]
A phase 1 trial is evaluating arginine in combination with whole-brain radiation therapy for brain metastases and is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: An BE Study to Compare 10mg & 20mg of IMP4297 Capsules in Healthy Chinese Subjects Under Fasting Condition [Phase 1]
Phase 1 bioequivalence study comparing 10 mg and 20 mg IMP4297 capsules in healthy Chinese subjects under fasting conditions has completed.
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: An BE Study to Compare 10mg & 20mg of IMP4297 Capsules in Healthy Chinese Subjects Under Fed Condition [Phase 1]
Phase 1 bioequivalence study comparing 10 mg and 20 mg IMP4297 capsules in healthy Chinese subjects under fed conditions has been completed.
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: A Study of Absorption-Distribution-Metabolism-Excretion (ADME) of [14C]IMP4297 to China Healthy Male Subjects [Phase 1]
Phase 1 ADME study in healthy Chinese male subjects to characterize absorption, distribution, metabolism, and excretion of the investigation…
-
CLINICAL_TRIALS research · 2025-09-16Clinical Trial Update: Ph I/II Trial of Systemic VSV-IFNβ-NIS in Combination With Checkpoint Inhibitor Therapy in Patients With Select Solid Tumors [Phase 1, Phase 2]
An ongoing Phase 1/2 study investigates systemic VSV-IFNβ-NIS in combination with checkpoint inhibitors for select solid tumors. The trial i…
-
CLINICAL_TRIALS trial_result · 2025-09-15Clinical Trial Update: Autologous TLPO Vaccine Basket [Phase 2]
Phase 2 trial of an autologous TLPO vaccine basket sponsored by Elios Therapeutics has been terminated.
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: A 1/2 Phase Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ASKB589 in Patients With Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial update on ASKB589 assessing safety, tolerability, pharmacokinetics, and antitumor activity in locally advanced or m…
-
CLINICAL_TRIALS trial_result · 2025-09-05Clinical Trial Update: Study of SYN818 With Olaparib for the Treatment of Locally Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 study evaluating SYN818 in combination with olaparib for locally advanced or metastatic solid tumors is currently recruiting, includ…
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors [Phase 1]
This update describes a Phase 1 trial of R-5780-01 in combination with PD-1 checkpoint inhibitors for solid tumors, currently recruiting.
-
CLINICAL_TRIALS withdrawal · 2025-09-04Clinical Trial Update: Major Complication Rate in Cancer Patients With Neutropenic Fever Potentially Eligible for a Hospital at Home Program
Clinical trial NCT04557709, sponsored by MD Anderson Cancer Center, evaluating major complication rate in cancer patients with neutropenic f…
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: A Trial of ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas [Phase 1]
A Phase 1 trial of ATG-101 in patients with advanced or metastatic solid tumors and mature B-cell Non-Hodgkin lymphoma has been terminated. …
-
CLINICAL_TRIALS trial_result · 2025-08-28Clinical Trial Update: DT-9081 Study in Participants With Advanced, Recurrent or Metastatic Solid Tumours [Phase 1]
A Phase 1 study of DT-9081 in adults with advanced, recurrent, or metastatic solid tumors has completed.
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: A Pharmacokinetic and Pharmacodynamic Study of DZ-002 in Patients With Advanced Solid Malignancies or Lymphoma [Phase 1]
Phase 1 pharmacokinetic and pharmacodynamic study of DZ-002 in patients with advanced solid malignancies or lymphoma has completed.
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: AMT-116 in Patients With Advanced Solid Tumors [Phase 1]
This document describes an ongoing Phase 1 clinical trial of AMT-116 in patients with advanced solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-17Clinical Trial Update: A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849 [Phase 1, Phase 2]
This is a Phase I/II open-label clinical trial evaluating the safety, tolerability, PK, and preliminary efficacy of FB849 in patients with a…
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: A Trial of HRS-6213 in Healthy Subjects and Patients With Solid Tumors [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating HRS-6213 in healthy subjects and patients with solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: A Study of CS5001 in Patients With Advanced Solid Tumors and Lymphomas [Phase 1]
CS5001 is being evaluated in a Phase 1 study for patients with advanced solid tumors and advanced lymphoma, with recruitment ongoing.
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Evaluation of Different Analysis Methods for Circulating Tumor Cells, Circulating Endothelial Cell, and Circulating Tumor DNA in Patient Followed for a Tumoral Pathology [NA]
A completed clinical trial evaluating different analysis methods for circulating tumor cells, circulating endothelial cells, and circulating…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Clinical Evaluation of 177Lu-AB-3PRGD2 in Various Solid Tumors With Integrin αvβ3 Positive Expression [Phase 1]
Phase 1 clinical evaluation of 177Lu-AB-3PRGD2 in various solid tumors with integrin αvβ3 expression. The study is currently recruiting.